MB Endobiobalansas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 0 |
| - |
| 0 |
| 0 |
| - |
| - |
| - |
| 0 |
| 0 |
| 0 |
| 0 |
| - |
| - |
| - |
| - |
| - |
| 0 |
| 2024 |
|---|
| 840 |
| - |
| 605 |
| 605 |
| - |
| 100.00 |
| 72.02 |
| 605 |
| 235 |
| 0 |
| 840 |
| 0.72 |
| 0.39 |
| - |
| - |
| 72.02 |
| 605 |
| 2025 |
|---|
| 600 |
| - |
| -382 |
| -382 |
| - |
| 100.00 |
| -63.67 |
| 223 |
| 235 |
| 0 |
| 458 |
| 0.37 |
| 1.05 |
| - |
| - |
| -63.67 |
| -382 |
| 2025 |
|---|
| 600 |
| - |
| -382 |
| -382 |
| - |
| 100.00 |
| -63.67 |
| 223 |
| 235 |
| 0 |
| 458 |
| 0.37 |
| 1.05 |
| - |
| - |
| -63.67 |
| -382 |
Turnover (€)
2025
Turnover (€)
600 €-29 % *
Sales per employee (€)
-Profit before tax (€)
-382 €-163 % *
Net Profit (€)
-382 €-163 % *
Profit per employee (€)
-Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-63.67 %-188.41 % *
Equity (€)
223 €-63 % *
Amounts Payable And Liabilities (€)
235 €0 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
458 €-45 % *
Working capital requirement
0.37 -48.61 % *
Debt-to-equity ratio
1.05 169.23 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
-63.67 %-188.41 % *
EBIT (€)
-382 €-163 % *
